Abcodia appoints Dr Wendy Alderton director of sciences
This article was originally published in Scrip
Executive Summary
Abcodia, a discoverer of molecular biomarkers for disease diagnosis and screening, has appointed Dr Wendy Alderton director of science. Dr Alderton has experience of project management from GlaxoSmithKline, Millennium Pharmaceuticals, Piramed and Summit. Her areas of expertise include oncology, neuroscience and inflammation.